Dr. Woller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5169 S. Cottonwood St.
Suite 307
Murray, UT 84157Phone+1 801-507-3310Fax+1 801-507-3375
Summary
- Dr. Woller’s academic interest is in the arena of thromboembolism and anticoagulation management. With a particular interest in the prevention of venous thromboembolic disease, Dr. Woller is investigator on multiple ongoing and recently completed clinical trials including two NIH-funded studies (COAG, GIFT) and served as site PI for one (GIFT). Dr. Woller is presently serving as Co-Chair for the American College of Chest Physicians (ACCP) Clinical Practice Guideline that addresses antithrombotic therapy for venous thromboembolic disease, and as was a panelist for the Vascular Access Appropriateness Panel housed at the University of Michigan. Dr. Woller is an invited panelist for the Centers for Disease Control and Prevention (CDC) Risk Assessment Model for the Prevention of Venous Thromboembolic Disease in Medical Patients program.
Dr. Woller is Professor of Medicine, University of Utah School of Medicine, Professor in Research, Intermountain Healthcare, and is a recognized teacher who received the Intermountain Medical Center Housestaff Teaching Award (2011) and University of Utah School of Medicine Outstanding Faculty Teaching Award (2012). Dr. Woller, Fellow of the American College of Chest Physicians (FCCP) and Fellow of the American College of Physicians (FACP), was recently elected to serve as the next Governor for the Utah Chapter of the American College of Physicians. Dr. Woller's research group was awarded the 2015 U.S. Centers for Disease Control and Prevention (CDC) Healthcare-Associated Venous Thromboembolism (HA-VTE) Prevention Challenge Award.
Dr. Woller received his medical degree from Northwestern University Medical School in 2000. Dr. Woller completed his residency at the University of Utah Hospital (2003) then served as Chief Medical Resident in 2003-04. Dr. Woller is Board Certified in Internal Medicine and attends at the Intermountain Medical Center, Murray UT where he serves as Chair of Medicine.
Education & Training
- University of Utah HealthResidency, Internal Medicine, 2000 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2000
- University of Wisconsin-MilwaukeeB.S., Biological Sciences, 1990 - 1993
Certifications & Licensure
- UT State Medical License 2001 - 2026
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- The Outstanding Faculty Teaching Award from among entire U of U University of Utah Department of Medicine, 2012
- Flagship Presentation Thrombosis Clinic, Intermountain Medical Center, 2012
- Golden Apple Award for Excellence in Teaching Intermountain Medical Center Transitional Year Residents, 2011
- Join now to see all
Clinical Trials
- Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Start of enrollment: 2011 Aug 01
- Weight Based Enoxaparin in Trauma Patients Start of enrollment: 2013 Jul 01
- Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism Start of enrollment: 2024 Mar 01
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.Anna L Parks, Scott M Stevens, Scott C Woller
Thrombosis Research. 2024-09-01 - Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical pat...Scott C Woller, Scott M Stevens, Joseph R Bledsoe, James Hellewell, Adam Kraft
Research and Practice in Thrombosis and Haemostasis. 2024-08-01 - 7 citationsAntithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021.Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, Kevin Doerschug, Geert-Jan Geersing
Chest. 2024-08-01
Journal Articles
- Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel ReportKearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Moores L, Chest, 1/1/2016
- Guidance for the evaluation and treatment of hereditary and acquired thrombophiliaStevens SM, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD, J Thromb Thrombolysis, 1/1/2016
- The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) initiative: A summary and review of peripherally inserted central catheter and venous catheter app...Stevens SM, Evans RS, J Hosp Med, 1/1/2015
- Join now to see all
Abstracts/Posters
- Assessment of the Safety and Efficiency of Using an Age Adjusted D Dimer Threshold to Exclude Suspected Pulmonary EmbolismStevens SM, Adams DM, Journal of Vascular Surgery, 1/12/2015
- Long term population based outcomes of novel oral anticoagulants compared to warfarin among long term anticoagulated patients: a propensity matched analysisJacobs V, May HT, Bair TL, Anderson JL, Crandall BG, Cutler M, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Bunch TJ, Circulation, 1/1/2015
- Implications Of Increasing The D Dimer Threshold In Patients With A Lower Pretest Probability To Exclude Pulmonary Embolism Prior To CT Pulmonary AngiographyAdams, DM, Stevens, SM, Evans RS, Lloyd, JF, Snow GL, Bledsoe JR, Lovelace TD, Aston VT, Elliott CG, Radiological Society of North America, Chicago, IL, 1/30/2014
- Join now to see all
Lectures
- Anticoagulation with direct oral anticoagulants (DOACs) and advances in peri procedural interruption of anticoagulation: BridgingIntermountain Medical Center Murray, UT - 1/1/2016
- Anticoagulation, Novel AgentsIntermountain Medical Center Murray, UT - 1/1/2015
- Anticoagulation to Prevent DVT/PE in the Orthopedics PatientMurray, UT - 1/1/2015
- Join now to see all
Other
- A Better Worldwide Best PracticeWoller, SC, Intermountain Stories, Newsletter for the Central Region.Salt Lake City: Intermountain Healthcare
1/25/2016 - New Guidelines Promote Individualized Patient Care at IMC (television interview)Woller SC, Salt Lake City: ABC 4 Utah
http://www.good4utah.com/news/local-news/new-guidelines-promote-individualizedpatient-care-at-imc.
1/22/2015 - Blood clots can be deadly, IMC researching new treatments (television interview)Woller SC, Salt Lake City: ABC 4 Utah
http://www.good4utah.com/story/d/story/blood-clots-can-be-deadly-imcresearching-new-trea/17052/b-f8Mli6s0uV3-0aDZKxyw
1/9/2015 - Join now to see all
Press Mentions
- Managing DOACs in Primary CareApril 25th, 2022
- What’s the Best Blood Thinner for a Blood Clot in Your Legs?December 9th, 2021
- CHEST Releases New Clinical Guidelines for Management of Venous ThromboembolismAugust 5th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: